Corona crisis: Nasal vaccine shows good results in trial

Bharat Biotech, a company doing trials on the Corona vaccine, has said that next year, single dose vaccine will be available. Two drops of the vaccine will be injected into the nose. Bharat Biotech, working with ICMR, claims that vaccines will be available from next year.  Moderna has claimed that its vaccine has proved to be 94.5% effective in protecting against infection. This is the second US company to announce success in the trial of the Corona vaccine.